Indeed, our finding that SAMHD1 mutations associate with both elevated mtDNA-CN levels and risk of breast cancer belies the prevailing notion that higher mtDNA-CN is always a protective signature of proper MT function and healthy cells. This evidence concerns the gene SAMHD1 and breast carcinoma.